Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Stephanie Slevin

Postdoctoral Scientist

I have always been interested in Biology especially in Immunology and mechanisms of disease pathogenesis. I carried out my undergraduate degree at the University College of Cork (UCC) where I specialised in Physiology. I then undertook a Masters in Regenerative Medicine at the National University of Ireland, Galway (NUIG) identifying monocyte subpopulations in Diabetes and Obesity. I was awarded a PhD scholarship by Molecular Medicine Ireland under the Clinical and Translational Research Scholars Programme at NUIG and my research investigated the acute effects of anti-TNF therapy on peripheral blood mononuclear cells in IBD.

Current project:

steph-slevin-hfg-apr2016-n3.jpgDefining the expression of LAG-3, an immune checkpoint regulator in circulating and tissue leukocytes in IBD patients.


Slevin, Stephanie, M. and Egan, Laurence, J. (2015) New Insights into the Mechanisms of Action of Anti–Tumor Necrosis Factor-α Monoclonal Antibodies in Inflammatory Bowel DiseaseInflamm Bowel Dis. 2015 Dec;21(12):2909-20.